Trial Profile
Phase III Randomised Study on Liposomal Cytarabine (DepoCyte) vs. Intrathecal Triple for CNS-Treatment During Maintenance Therapy in High-Risk Acute Lymphoblastic Leukemia Patients in NOPHO ALL 2008 Treatment Protocol.
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 18 Jan 2022
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Asparaginase; Dexamethasone; Mercaptopurine; Methotrexate; Prednisolone sodium succinate
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 21 Jun 2020 Results of an analysis from following clinical trials: Dutch: DCOG-ALL10/11 trials, Australian: ANZCHOG-ALL8 and AIEOP-BFM-ALL2009 trials, UK: ALL2003 trial and NOPHO-ALL2008 trial assessing association between Down syndrome and clinical outcome presented at the 25th Congress of the European Haematology Association
- 02 May 2016 This trial is 'prematurely ended' in Lithuania, according to European Clinical Trials Database.
- 17 Mar 2012 Additional location (Lithuania) added and additional lead trial centre identified as reported by European Clinical Trials Database record.